Compare Apple Inc (AAPL) vs Dolby Laboratories, Inc. (DLB) Price & Performance

Apple (AAPL) trades at $314.03, up 0.44% today, with a bullish technical signal from moving averages and a consensus analyst price target of $329.62. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $2.01 surpassing the $1.95 estimate. Revenue grew to $416.16B in 2025, and net income reached $112.01B. The company maintains strong profitability with a 47.86% gross margin and 27.15% net margin, though valuation ratios like P/E of 37.61 are elevated. A dividend of $0.27 is scheduled for payment on May 14, 2026.

The outlook for AAPL remains positive driven by earnings beats and AI opportunities, but risks include high valuation, competitive pressures, and potential regulatory scrutiny. Institutional sentiment is bullish with 62.73% buy ratings, though technical indicators show mixed signals with RSI suggesting mild overbought conditions near-term.

DLB trades at $49.31, down 3.6% today, with technical indicators showing bearish momentum. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.37 versus $1.31 expected. Revenue remains stable at $1.35B for 2025, with robust gross margins of 87.44%. Recent developments include FDA progress for zervimesine in DLB psychosis and recognition as GM's 2025 Supplier of the Year.

Despite near-term technical weakness, DLB's patent-protected revenue streams and high profitability support long-term value. The consensus price target of $87.50 implies significant upside, but investors face risks from cyclical end-markets and potential dilution from drug development. The stock presents a contrarian opportunity with 47% analyst buy ratings amid current bearish sentiment.